Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma

por Zhang, Guojun, Yang, Chuan, Zhao, Caixia, Xian, Feng, Qing, Dong, Guo, Qiyu, Song, Junmei, Liu, Xilin, Bie, Jun
Publicado 2023

Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?

por Huang, Yuanheng, Su, Xiaodong, Guo, Qiyu, Luo, Guangyu, He, Haoqiang, Cai, Peiqiang, Cai, Muyan, Yue, Haodong, Wang, Zhiqiang, Yang, Guozhen, Lin, Peng, Zhang, Xu
Publicado 2023

Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial

por Yang, Guozhen, Su, Xiaodong, Huang, Yuanheng, Luo, Guangyu, Wang, Zhiqiang, Cai, Peiqiang, Zheng, Yating, Bei, Ting, Huang, Mengli, Bai, Yuezong, He, Haoqiang, Xiang, Jin, Cai, Muyan, Zhong, Jiudi, Guo, Qiyu, Zhang, Xu
Publicado 2023

Early versus Late Application of Subthalamic deep brain Stimulation to Parkinson’s disease patients with motor complications (ELASS): protocol of a multicentre, prospective and obs...

por Jiang, Lulu, Poon, Wai Sang, Moro, Elena, Xian, Wenbiao, Yang, Chao, Zhu, Xian Lun, Gu, Jing, Cai, Xiaodong, Liu, Jinlong, Mok, Vincent, Liu, Yanmei, Xu, Shaohua, Guo, Qiyu, Chen, Wanru, Chen, Ling
Publicado 2017

Eight‐year follow‐up outcome of subthalamic deep brain stimulation for Parkinson’s disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulatio...

por Jiang, Lulu, Chen, Wanru, Guo, Qiyu, Yang, Chao, Gu, Jing, Xian, Wenbiao, Liu, Yanmei, Zheng, Yifan, Ye, Jing, Xu, Shaohua, Hu, Yu, Wu, Lei, Chen, Jie, Qian, Hao, Fu, Xiaoli, Liu, Jinlong, Chen, Ling
Publicado 2021

The efficacy and safety of asleep and awake subthalamic deep brain stimulation for Parkinson’s disease patients: A 1-year follow-up

por Chen, Wanru, Zhang, Changming, Jiang, Nan, Jiang, Lulu, Guo, Qiyu, Gu, Jing, Xian, Wenbiao, Ling, Yuting, Liu, Yanmei, Zheng, Yifan, Wu, Lei, Yang, Chao, Xu, Shaohua, Hu, Yu, Yang, Yang, Chen, Jinhua, Xuan, Ruoheng, Liu, Yi, Liu, Jinlong, Chen, Ling
Publicado 2023

Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma

por Yang, Guozhen, Su, Xiaodong, Yang, Hong, Luo, Guangyu, Gao, Chan, Zheng, Yating, Xie, Wenzhuan, Huang, Mengli, Bei, Ting, Bai, Yuezong, Wang, Zhiqiang, Cai, Peiqiang, He, Haoqiang, Xiang, Jin, Cai, Muyan, Zhang, Yijun, Qu, Chunhua, Fu, Jianhua, Liu, Qianwen, Hu, Yi, Zhong, Jiudi, Huang, Yuanheng, Guo, Qiyu, Zhang, Xu
Publicado 2021